Dual GLP-1 RA + Amylin Analog (Cagrilintide)8 PubMed Citations

CagriSema (Cagrilintide + Semaglutide) Supplement Protocol

Evidence-based nutrient depletion risks and supplement recommendations for Developmental combination users.

Brand Names
Developmental combination
Mechanism

Cagrilintide is an amylin analog that co-targets the GLP-1 receptor, potentially enhancing satiety and weight loss effects with semaglutide. Combined, they act on GLP-1 receptors.

FDA Status

Clinical trials ongoing (REDEFINE program, Phase 2 completed, Phase 3 ongoing as of April 2026). Not yet FDA approved.

Common Doses
2.4 mg Cagrilintide + 2.4 mg Semaglutide weekly SC injection

Nutrient Depletion Risks

8 nutrients affected by CagriSema (Cagrilintide + Semaglutide)

Vitamin DHIGH

Reduced caloric intake, rapid weight loss.

SupplementVitamin D3 (cholecalciferol)
Dose2,000-5,000 IU/day
MonitorCheck 25(OH)D at baseline, 3 months, 6 months, then annually
IronHIGH

Reduced food intake, potential GI side effects.

SupplementIron bisglycinate
Dose18-36mg/day if deficient
MonitorCheck ferritin + transferrin saturation at baseline and every 6 months
Supplement only if deficient. Take separately from calcium.
ProteinHIGH

Inadequate protein intake due to appetite suppression and risk of lean mass loss with significant weight loss.

SupplementProtein powder (whey, collagen, or plant-based)
Dose1.2-1.6g protein per kg ideal body weight daily
MonitorTrack prealbumin, albumin. Monitor lean mass if concerns.
CalciumMODERATE-HIGH

Reduced food intake.

SupplementCalcium citrate
Dose500-1,000mg/day in divided doses
MonitorCheck serum calcium, PTH. Consider DEXA if high risk.
Vitamin B12MODERATE

Reduced intake, potential for impaired absorption.

SupplementMethylcobalamin sublingual
Dose1,000-2,500 mcg/day
MonitorCheck serum B12 + MMA at baseline and 6 months
Thiamine B1MODERATE

Reduced intake, potential for deficiency with prolonged caloric restriction and GI symptoms.

SupplementThiamine HCl or benfotiamine
Dose50-100mg/day
MonitorCheck thiamine levels if symptoms (fatigue, neuropathy, confusion)
MagnesiumMODERATE

Reduced food intake. GI side effects may further deplete.

SupplementMagnesium glycinate
Dose200-400mg elemental magnesium/day
MonitorCheck RBC magnesium
Omega 3MODERATE

Reduced dietary intake of fatty fish.

SupplementEPA/DHA fish oil or algae omega-3
Dose1-2g EPA+DHA/day
MonitorCheck omega-3 index if available

Essential Supplement Stack

Priority-ranked supplements based on depletion evidence

Vitamin D3With largest meal
2,000-5,000 IUHIGH
Protein powderMorning or post-workout
20-40g/dayHIGH
Magnesium glycinateBefore bed
200-400mg elementalHIGH
Vitamin B12 sublingualMorning
1,000 mcgMODERATE
Calcium citrateWith meals, split doses
500mgMODERATE

Recommended Additions

Additional supplements based on individual risk factors

Omega-3 EPA/DHAWith meal
1-2gMODERATE
Iron bisglycinateEmpty stomach or with vitamin CRequires blood test confirmation
18-36mgONLY IF DEFICIENT
Vitamin K2 MK-7With vitamin D
100-200 mcgLOW-MODERATE
Thiamine (B1)MorningConsider higher dose/priority if GI symptoms, rapid weight loss, or history of malnutrition.
50-100mgLOW-MODERATE

Lab Monitoring Schedule

Recommended testing timeline while on this medication

Baseline
25(OH)DB12MMAFerritinTransferrin satCBCCMPAlbuminPrealbuminHbA1cLipid panelThiamine (if symptomatic)
3 Months
25(OH)DFerritinB12AlbuminCMP
6 Months
Full panel repeat
12 Months
Full panel + DEXA if available

Every 6-12 months, or as clinically indicated

Drug Interactions

5 known interactions to monitor

MetforminMODERATE

Both reduce B12 absorption. Combined use increases B12 deficiency risk.

ActionMonitor B12 more frequently. Consider higher B12 supplementation (2,500 mcg sublingual).
PPIs (omeprazole, etc.)MODERATE

Further reduces B12 and magnesium absorption

ActionConsider sublingual B12 and magnesium glycinate
WarfarinMODERATE

Vitamin K2 supplementation may affect INR

ActionMonitor INR if adding K2
Thyroid medications (levothyroxine)MODERATE

Delayed gastric emptying may alter levothyroxine absorption

ActionTake thyroid meds 60 min before any meal, on empty stomach
Semaglutide (monotherapy)HIGH

CagriSema is a combination; using semaglutide alone would miss the synergistic effects and potentially different side effect profile.

ActionEnsure patient is prescribed the CagriSema combination product if indicated.

CagriSema (Cagrilintide + Semaglutide)-Specific Notes

Important considerations unique to this medication

cagrisema specific

CagriSema combines semaglutide's GLP-1 agonism with cagrilintide's GLP-1 receptor co-targeting (as an amylin analog). It has shown superior weight loss and HbA1c reduction compared to semaglutide alone in Phase 2 trials (PMID: 40544433, PMID: 40544432). The potent GLP-1 receptor activation amplifies risks associated with semaglutide.

gi considerations

Nausea, vomiting, diarrhea are common, especially during dose titration. Choose supplement forms that minimize GI distress.

timing recommendations

Take fat-soluble vitamins (D) with the largest meal. Take iron separately from calcium and coffee (2+ hours apart). Take magnesium before bed. Take thyroid medications 60+ minutes before any meal, on empty stomach.

Evidence Citations

8 PubMed-indexed studies referenced

Add this protocol to your profile

Your Daily Intelligence and Ask Dose will be personalized for the CagriSema (Cagrilintide + Semaglutide) protocol, including nutrient depletion alerts and interaction warnings.

Sign in required. Your health data stays encrypted and private.

Medical Disclaimer

This protocol is for educational purposes only and is not medical advice. Supplement recommendations are adjunctive support, not replacements for prescribed medication. Always consult your prescribing physician before adding supplements to your CagriSema (Cagrilintide + Semaglutide) regimen. Individual needs vary based on health status, diet, and concurrent medications. Scan Dose is not affiliated with any pharmaceutical manufacturer.

Scan Dose does not sell supplements or accept affiliate commissions. All content is independently researched.